Fulltext

Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma

Gakis, G. ; Morgan, T. M. ; Daneshmand, S. ; Keegan, K. A. ; Todenhöfer, T. ; Mischinger, J. ; Schubert, T. ; Zaid, H. B. ; Hrbacek, J. ; Ali-El-Dein, B. ; Clayman, R. H. ; Galland, S. ; Olugbade, K. ; Rink, M. ; Fritsche, H.-M ; Burger, M. ; Chang, S. S. ; Babjuk, M. ; Thalmann, G. N. ; Stenzl, A. ; Efstathiou, J. A.

In: Annals of Oncology, 2015, vol. 26, no. 8, p. 1754-1759

Aggiungi alla tua lista
    Titre
    • Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma
    Auteur
    • Gakis, G.. Department of Urology, University of Tuebingen, Tuebingen, Germany
    • Morgan, T. M.. Department of Urology, University of Michigan, Ann Arbor, USA
    • Daneshmand, S.. Institute of Urology, USC/Norris Comprehensive Cancer Center, Los Angeles
    • Keegan, K. A.. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, USA
    • Todenhöfer, T.. Department of Urology, University of Tuebingen, Tuebingen, Germany
    • Mischinger, J.. Department of Urology, University of Tuebingen, Tuebingen, Germany
    • Schubert, T.. Department of Urology, University of Tuebingen, Tuebingen, Germany
    • Zaid, H. B.. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, USA
    • Hrbacek, J.. 2nd Medical School, Department of Urology, Charles University, Prague, Czech Republic
    • Ali-El-Dein, B.. Urology and Nephrology Center, Mansoura Clinic, Mansoura, Egypt
    • Clayman, R. H.. Department of Radiooncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
    • Galland, S.. Department of Radiooncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
    • Olugbade, K.. Department of Urology, University of Michigan, Ann Arbor, USA
    • Rink, M.. Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg
    • Fritsche, H.-M. Department of Urology, University Hospital Regensburg, Regensburg, Germany
    • Burger, M.. Department of Urology, University Hospital Regensburg, Regensburg, Germany
    • Chang, S. S.. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, USA
    • Babjuk, M.. 2nd Medical School, Department of Urology, Charles University, Prague, Czech Republic
    • Thalmann, G. N.. Department of Urology, University Hospital Bern, Bern, Switzerland
    • Stenzl, A.. Department of Urology, University of Tuebingen, Tuebingen, Germany
    • Efstathiou, J. A.. Department of Radiooncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
    Type de document
    • Postprint
    Langue
    • Inglese
    Publié dans
    • Annals of Oncology, 2015, vol. 26, no. 8, p. 1754-1759. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:302923
    Summary
    This is the first series that suggests a prognostic benefit of neoadjuvant treatment in a consecutive series of patients who underwent perioperative chemotherapy plus surgery for advanced primary urethral carcinoma. Further studies should yield a better understanding of how perioperative chemotherapy exerts a positive effect on survival in order to selectively advocate its use in advanced primary urethral carcinoma